Requests that the FDA include additional warnings that should be added to prescribing information on Hormonally-active contraceptives (HCs) and the development of autoimmune diseases
🏛 Food and Drug Administration (FDA)FDA-2026-P-3869
Documents
10
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.